Navigation Links
Rubbermaid Commercial Products Debuts Industry's First Disposable Microfiber
Date:9/23/2013

WINCHESTER, Va., Sept. 23, 2013 /PRNewswire/ -- Rubbermaid Commercial Products (RCP), the leader in innovative, solutions-based commercial products, today announced the availability of the Rubbermaid HYGEN™ Disposable Microfiber System for efficient cleaning and infection prevention in the healthcare environment.

The Rubbermaid HYGEN Disposable Microfiber System is designed and proven by third-party testing to remove 99.9 percent of microbes, which includes C. diff, a bacteria that can cause potentially life-threatening infections. The Rubbermaid HYGEN Disposable Microfiber System also features built-in scrubbers that enable complete dirt removal without smearing.

"With healthcare-associated infections resulting in the loss of tens of thousands of lives and costing billions, microbe removal is crucial," said Alison Kapp, marketing manager, hard surface commercial cleaning for Rubbermaid Commercial Products. "What people don't realize is that even if microbes are killed by chemicals, they remain on surfaces and become food for live pathogens. We're excited to debut a solution that changes the cleaning game by removing these microbes to facilitate infection prevention and ensure patient safety."

The first product to deliver the cleaning power and efficacy of microfiber at a disposable price point, the Rubbermaid HYGEN Disposable Microfiber System enables cleaning staff to do more with less to improve productivity. The highly absorbent microfiber yarn used provides 50 percent more surface area coverage per cloth compared to leading competitors. The disposable microfiber mop can be used wet or dry and is compatible with Rubbermaid Pulse™ or Rubbermaid HYGEN Charging Bucket.

Application areas include occupied and discharge patient rooms; emergency and isolation rooms; intensive care units; nurses' stations, X-ray stations and MRI stations; and other public areas.


'/>"/>
SOURCE Rubbermaid Commercial Products
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
2. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
3. Acella Pharmaceuticals Announces a New Addition to the Commercial Team
4. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
5. New Executive Vice President Commercial Appointed
6. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
7. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
8. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
9. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
10. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
11. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LONDON , September 19, 2014 ... hat Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, ... abdeckt. Die interaktive PDF, verfügbar unter pharmaserialisation.com ... an dem sie jeweils in Kraft treten. ... der Serialisierung nicht länger um das "ob", sondern ...
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014 /PRNewswire/ ... provider of advanced cancer genome analysis and testing ... in discovering and developing highly selective kinase inhibitors ... comprehensive genomic study of malignant mixed Mullerian tumors ... female reproductive system, also known as carcinosarcoma. The ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Dec. 13, 2010 Masimo ... new clinical study demonstrating the accuracy of its latest ... week at the American Association of Respiratory Care,s ... Vegas. The largest gathering of respiratory care clinicians in ...
... BioTrends Research Group, Inc. finds that on most ... for the management of a multiple sclerosis (MS) symptom, ... product awareness, interest, satisfaction, the managed care process and ... launch, patient requests play a less impactful role in ...
Cached Medicine Technology:New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 2New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 3New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 4New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 5New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 6Acorda's Ampyra Sustains High Levels of Interest Seven Months After Launch With Favorable Future Share Projections 2
(Date:9/19/2014)... By Alan Mozes ... (HealthDay News) -- Cancer patients burdened by stress and ... for complications following their operation, a new study suggests. ... "deficit" appeared to have a nearly three times greater ... or good quality of life. "We,ve long known ...
(Date:9/19/2014)... leading anti-ageing clinic has called its HGH Therapy ... grown tremendously across USA in the last decade with new ... has far reaching benefits for ageing men and women and ... active lifestyle even beyond their middle age. , Explaining ... said, “HGH or Human Growth hormones are the building blocks ...
(Date:9/19/2014)... IRVINE, CA (PRWEB) September 19, 2014 In ... has been an active part of the project’s social ... this movement, which aims to re-define the perception of beauty ... Beauty Project began as an idea by Shelly Baer and ... showed disabled women as sexy and beautiful. Ginny Dixon, Wendy ...
(Date:9/19/2014)... two-generation approaches to reducing poverty that help children ... researchers, advocates, and foundations. By combining education and ... to jobs that offer a path out of ... children, these programs aim to improve the life ... new report from the National Center for Children ...
(Date:9/19/2014)... Hills, NY (PRWEB) September 20, 2014 As ... Prabha Krishnan DMD in Queens, NY now reminds area patients ... more than 80% of our population affected by gum disease, ... any longer.” , For over 20 years Dr. Krishnan has ... Forest Hills office location. “Most patients that come in due ...
Breaking Medicine News(10 mins):Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3
... ARBOR, Mich. Only a third of patients with ... before their initial surgery, according to a new study ... Whats more, women who did discuss reconstruction up front ... compared to those women who did not discuss reconstruction. ...
... Calif., Dec. 20 ISTA Pharmaceuticals,Inc. (Nasdaq: ... a New Drug,Application (NDA) to the U.S. Food ... Company is seeking approval for Xibrom QD,as a ... Xibrom(TM) (bromfenac ophthalmic solution), Xibrom is ...
... New research,published in the December issue of Pediatrics ... can lose weight while substituting an,ounce of peanuts ... choices. The,study, "Weight Loss in Overweight Mexican American ... and Overweight" (FLOW),Prevention Program, which is in a ...
... Mich., Dec. 20 Oakwood Healthcare,Inc. (OHI) today became ... most up-to-date and comprehensive pricing information for,hundreds of surgeries, ... This is a natural step forward as Oakwood was,the ... key,quality outcomes on its Web site more than two ...
... of Howard G. Smith,announces a September 4, 2007, ... in,the securities class action lawsuit filed on behalf ... Pharmaceuticals, Inc. ("Threshold,Pharmaceuticals" or the "Company")(Nasdaq: THLD ... (the "Class Period"), including purchasers in Threshold,s,February 4, ...
... humanitarian organization distorts ... history and law, WASHINGTON, Aug. ... Johnson & Johnson (J&J), the American,Red Cross today released a detailed rebuttal, ... emblem. "The mission of the Red Cross is to prevent, prepare ...
Cached Medicine News:Health News:Most breast cancer surgeons don't talk to patients about reconstruction options, U-M study finds 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 3Health News:Oakwood is First Healthcare System in Southeast Michigan to Post Pricing Information on Web Site 2Health News:Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc. 2Health News:American Red Cross Defends Use of Emblem and Mission 2Health News:American Red Cross Defends Use of Emblem and Mission 3Health News:American Red Cross Defends Use of Emblem and Mission 4Health News:American Red Cross Defends Use of Emblem and Mission 5Health News:American Red Cross Defends Use of Emblem and Mission 6
4 mm disposable bevel blade. Malleable shafts. Flat spot on handle designed to guide knife in perforation....
Consist of 6 disposable bevel blades (N0522) and chuck handle (0521). Malleable shafts. Designated most popular model or size....
Straight 9 mm downcutting Royce blade. Can be placed in closed handle for protection. Handle length folded 109 mm, 4.3 inches. Blade can be set automatically and rigidly at any point from straight to...
2 mm diameter blade. Angled 60 degrees. Sharp. Round handle....
Medicine Products: